RemediumOne is involved in three Gastroenterology clinical trials, with two ongoing studies in multiple centers spread across the country, recruiting 30+ study participants.
August 3, 2022
Moderately to Severely Active Crohn’s Disease (CD)
Crohn’s disease is a type of inflammatory bowel disease (IBD). It causes inflammation of your digestive tract, which can lead to abdominal pain, severe diarrhea, fatigue, weight loss and malnutrition. The prevalence of CD in […]READ MORE